# Oxford BioDynamics PLC > Oxford BioDynamics Plc (AIM: OBD) is an international biotechnology company, advancing personalized healthcare by developing and commercializing precision clinical diagnostic tests for life-changing diseases. Currently OBD has two commercially available products: the EpiSwitch® PSE (EpiSwitch Prostate Cancer Detection Test) and EpiSwitch® CiRT (Checkpoint Inhibitor Response Test) blood tests. PSE boosts the predictive accuracy of a PSA test from 55% to 94% when testing the presence or absence of prostate cancer. CiRT is a highly accurate (85%) predictive response test to immuno-oncology checkpoint inhibitor treatments. Location: Oxford,, United Kingdom ## Categories - Healthcare & Medical ## Documents - [Business profile](https://directory.websdocs.com/business/oxford-biodynamics-plc) - [Directory JSON](https://directory.websdocs.com/business/oxford-biodynamics-plc.json) - [Schema.org JSON-LD](https://directory.websdocs.com/business/oxford-biodynamics-plc/schema.jsonld) - [Directory sitemap](https://directory.websdocs.com/sitemap.xml) - [Directory discovery manifest](https://directory.websdocs.com/.well-known/asg-directory.json) - [Directory OpenAPI](https://directory.websdocs.com/api/openapi.json) - [Official website](https://www.oxfordbiodynamics.com/)